Alkermes (ALKS) Change in Receivables (2010 - 2026)

Alkermes' (ALKS) quarterly Change in Receivables came in at $23.2 million in Q1 2026, up 135.27% year-on-year from $9.9 million in Q1 2025, and up 213.98% on a QoQ basis from -$20.4 million in Q4 2025.

Alkermes (ALKS) Change in Receivables (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Change in Receivables data on file, last reported at $23.2 million in Q1 2026.

  • On a quarterly basis, Change in Receivables rose 135.27% year-over-year to $23.2 million in Q1 2026; TTM through Mar 2026 was $38.5 million, a 1249.84% increase from a year earlier, with the FY2025 full-year figure at -$50.5 million, down 197.02% from the prior year.
  • Change in Receivables for Q1 2026 stood at $23.2 million, up from -$20.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for ALKS reached as high as $65.3 million in Q2 2023 and fell as low as -$65.8 million in Q1 2025.
  • Historically, Change in Receivables has averaged $2.6 million across 5 years, with a median of $795000.0 in 2024.
  • Across the five-year window, Change in Receivables surged 1695.8% in 2023 and sank 295.87% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at $30.8 million in 2022, then tumbled by 116.95% to -$5.2 million in 2023, then jumped by 431.76% to $17.3 million in 2024, then sank by 217.62% to -$20.4 million in 2025, then jumped by 213.98% to $23.2 million in 2026.
  • Per Business Quant data, the three most recent Change in Receivables figures were $23.2 million in Q1 2026, -$20.4 million in Q4 2025, and -$512000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 23.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.22 Mn
Mar 31, 2026 23.22 Mn
Dec 31, 2025 -20.37 Mn
Dec 31, 2025 -20.37 Mn
Sep 30, 2025 -512,000.00
Sep 30, 2025 -512,000.00
Jun 30, 2025 36.20 Mn
Jun 30, 2025 36.20 Mn
Mar 31, 2025 -65.83 Mn
Mar 31, 2025 -65.83 Mn
Dec 31, 2024 17.32 Mn
Dec 31, 2024 17.32 Mn
Sep 30, 2024 795,000.00
Sep 30, 2024 795,000.00
Jun 30, 2024 50.57 Mn
Jun 30, 2024 50.57 Mn
Mar 31, 2024 -16.63 Mn
Mar 31, 2024 -16.63 Mn
Dec 31, 2023 -5.22 Mn
Dec 31, 2023 -5.22 Mn